Skip to main content

Advertisement

SpringerLink
Log in

Survey on the management of orbital and intraocular tumors among oculofacial surgeons in the Asia-Pacific region

  • Review
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

A web-based anonymous survey was performed to assess the common practices of oculofacial surgeons in the management of orbital and intraocular tumors in the Asia-Pacific region. The questionnaire comprised a series of questions covering controversial topics sent via email to 131 oculofacial surgeons across 14 countries in the Asia-Pacific region. A total response rate of 61.7 % was achieved from May to December 2012. The most common benign orbital tumor was cavernous hemangioma (39.6 %) and the most common malignant orbital tumor was lymphoma (85.7 %). 40 % of surgeons recommended orbital radiation, for which the most common indications were thyroid eye disease (70.0 %) and malignancy (30.0 %). The most common orbitotomy approach was lateral (79.2 %). Most surgeons (87.1 %) offered enucleation for retinoblastoma, but there was also a significant proportion that offered chemoreduction with transpupillary thermotherapy or cryotherapy (58.1 %). Fewer surgeons offered brachytherapy (16.1 %) and intra-arterial chemotherapy (6.5 %). When performing enucleation for retinoblastoma, 81.8 % of surgeons performed a primary orbital implant placement. The most preferred type of implant was silicone/acrylic (90.2, 90.2 and 87.8 % for elderly, adults and children, respectively). The majority of surgeons used donor sclera (57.5 %) or no wrapping material at all (32.5 %). Almost all surgeons (95.1 %) did not drill and peg the implant for motility. We report the results of the first survey of oculofacial surgeons in the Asia-Pacific region on the management of intraocular and orbital tumors. In comparison with previous surveys performed in the USA and the UK, we found the practice patterns of the Asia-Pacific surgeons to be comparable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Su GW, Yen MT (2004) Current trends in managing the anophthalmic socket after primary enucleation and evisceration. Ophthal Plast Reconstr Surg 20:274–280

    Article  PubMed  Google Scholar 

  2. Viswanathan P, Sagoo MS, Olver JM (2007) UK national survey of enucleation, evisceration and orbital implant trends. Br J Ophthalmol 91:616–619

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Shah RD, Singa RM, Aakalu VK, Setabutr P (2012) Evisceration and enucleation: a national survey of practice patterns in the United States. Ophthalmic Surg Lasers Imaging 43:425–430

    Article  PubMed  Google Scholar 

  4. Scat Y, Liotet S, Carre F (1996) Epidemiological study of 1,705 malignant tumors of the eye and adnexa. J Fr Ophtalmol 19:83–88

    CAS  PubMed  Google Scholar 

  5. Lee SB, Au Eong KG, Saw SM, Chan TK, Lee HP (2000) Eye cancer incidence in Singapore. Br J Ophthalmol 84:767–770

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Cheng GY, Li B, Li LQ et al (2008) Review of 1,375 enucleations in the TongRen Eye Centre, Beijing. Eye (Lond) 22:1404–1409

    Article  CAS  Google Scholar 

  7. Samaila MO (2009) Malignant tumours of childhood in Zaria. Afr J Paediatr Surg 6:19–23

    Article  PubMed  Google Scholar 

  8. Shields JA, Shields CL, Scartozzi R (2004) Survey of 1,264 patients with orbital tumors and simulating lesions: the 2002 Montgomery Lecture, part 1. Ophthalmology 111:997–1008

    Article  PubMed  Google Scholar 

  9. Demirci H, Shields CL, Shields JA, Honavar SG, Mercado GJ, Tovilla JC (2002) Orbital tumors in the older adult population. Ophthalmology 109:243–248

    Article  PubMed  Google Scholar 

  10. Margo CE, Mulla ZD (1998) Malignant tumors of the orbit. Analysis of the Florida Cancer Registry. Ophthalmology 105:185–190

    Article  CAS  PubMed  Google Scholar 

  11. Chakrabarti AK, Biswas G, Das S (1993) Malignant orbital tumours: observation in north Bengal. J Indian Med Assoc 91:154–155

    CAS  PubMed  Google Scholar 

  12. Günalp I, Gündüz K (1995) Pediatric orbital tumors in Turkey. Ophthal Plast Reconstr Surg 11:193–199

    Article  PubMed  Google Scholar 

  13. Günalp I, Gündüz K, Ozkan M (1997) Causes of enucleation: a clinicopathological study. Eur J Ophthalmol 7:223–228

    PubMed  Google Scholar 

  14. Wilczyński M, Omulecki W (2004) Analysis of the causes of enucleations performed at the Department of Ophthalmology of the Medical University of Lódź. Klin Oczna 106:303–307

    PubMed  Google Scholar 

  15. Shields CL, Ramasubramanian A, Thangappan A et al (2009) Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Ophthalmology 116:544–551

    Article  PubMed  Google Scholar 

  16. Steibel H, Sela M, Pe’er J (1995) Changing indications for enucleations in Hadassah University Hospital, 1960–1989. Ophthalmic EpidemioI 2:123–127

    Article  Google Scholar 

  17. Spraul CW, Grossniklaus HE (1997-1998) Analysis of 24,444 surgical specimens accessioned over 55 years in an ophthalmic pathology laboratory. Int Ophthalmol 21:283–304

    Google Scholar 

  18. Shields JA, Shields CL, Sivalingam V (1989) Decreasing frequency of enucleation in patients with retinoblastoma. Am J Ophthalmol 108:185–188

    CAS  PubMed  Google Scholar 

  19. Gaton DD, Ehrlich R, Muzmacher L, Hamel N, Lusky M, Weinberger D (2008) Enucleations and eviscerations in a large medical center between the years 1981 and 2007. Harefuah 147:758–762, 840

    Google Scholar 

  20. Scat Y, Liotet S, Bellefqih S (1996) Etiology of enucleations. Apropos of 3,246 cases. J Fr Ophtalmol 19:242–247

    CAS  PubMed  Google Scholar 

  21. Gassler N, Lommatzsch PK (1995) Clinicopathologic study of 817 enucleations. Klin Monbl Augenheilkd 207:295–301

    Article  CAS  PubMed  Google Scholar 

  22. Vemuganti GK, Jalali S, Honavar SG, Shekar GC (2001) Enucleation in a tertiary eye care centre in India: prevalence, current indications and clinicopathological correlation. Eye (Lond) 15:760–765

    Article  CAS  Google Scholar 

  23. Halli RC, Mishra S, Kini YK, Kharkar VR, Hebbale MA (2011) Modified lateral orbitotomy approach: a novel technique in the management of lacrimal gland tumors. J Craniofac Surg 22:1035–1038

    Article  PubMed  Google Scholar 

  24. Arai H, Sato K, Katsuta T, Rhoton AL Jr (1996) Lateral approach to intraorbital lesions: anatomic and surgical considerations. Neurosurgery 39:1157–1162

    Article  CAS  PubMed  Google Scholar 

  25. Okay O, Daglioglu E, Akdemir G et al (2010) Lateral orbitotomy approach to orbital tumors: report of 10 cases. Turk Neurosurg 20:167–172

    PubMed  Google Scholar 

  26. Gönül E, Timurkaynak E (1998) Lateral approach to the orbit: an anatomical study. Neurosurg Rev 21:111–116

    Article  PubMed  Google Scholar 

  27. Maroon JC, Kennerdell JS (1984) Surgical approaches to the orbit. Indications and techniques. J Neurosurg 60:1226–1235

    Article  CAS  PubMed  Google Scholar 

  28. Paolini S, Santoro A, Missori P, Pichierri A, Esposito V, Ciappetta P (2006) Surgical exposure of lateral orbital lesions using a coronal scalp flap and lateral orbitozygomatic approach: clinical experience. Acta Neurochir (Wien) 148:959–963

    Article  CAS  Google Scholar 

  29. Kim JW, Yates BS, Goldberg RA (2009) Total lateral orbitotomy. Orbit 28:320–327

    Article  PubMed  Google Scholar 

  30. Harris GJ, Logani SC (1999) Eyelid crease incision for lateral orbitotomy. Ophthal Plast Reconstr Surg 15:9–16

    Article  CAS  PubMed  Google Scholar 

  31. Nemet A, Martin P (2007) The lateral triangle flap—a new approach for lateral orbitotomy. Orbit 26:89–95

    Article  PubMed  Google Scholar 

  32. Kiratli H, Bulur B, Bilgiç S (2005) Transconjunctival approach for retrobulbar intraconal orbital cavernous hemangiomas. Orbital surgeon’s perspective. Surg Neurol 64:71–74

    Article  PubMed  Google Scholar 

  33. Pelton RW (2009) The anterior eyelid crease approach to the orbit. Curr Opin Ophthalmol 20:401–405

    Article  PubMed  Google Scholar 

  34. Obuchowska I, Sherkawey N, Elmdhm S, Mariak Z, Stankiewicz A (2005) Clinical indications for enucleation in the material of Department of Ophthalmology, Medical Academy in Białystok in the years 1982–2002. Klin Oczna 107:75–79

    PubMed  Google Scholar 

  35. Phan LT, Hwang TN, McCulley TJ (2012) Evisceration in the modern age. Middle East Afr J Ophthalmol 19:24–33

    Article  PubMed Central  PubMed  Google Scholar 

  36. Hansen AB, Petersen C, Heegaard S, Prause JU (1999) Review of 1,028 bulbar eviscerations and enucleations. Changes in aetiology and frequency over a 20-year period. Acta Ophthalmol Scand 77:331–335

    Article  CAS  PubMed  Google Scholar 

  37. Setlur VJ, Parikh JG, Rao NA (2010) Changing causes of enucleation over the past 60 years. Graefes Arch Clin Exp Ophthalmol 248:593–597

    Article  PubMed  Google Scholar 

  38. Shields CL, Meadows AT, Leahey AM, Shields JA (2004) Continuing challenges in the management of retinoblastoma with chemotherapy. Retina 24:849–862

    Article  PubMed  Google Scholar 

  39. Canturk S, Qaddoumi I, Khetan V et al (2010) Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators. Br J Ophthalmol 94:1432–1436

    Article  CAS  PubMed  Google Scholar 

  40. Imhof SM, Moll AC, Schouten-van Meeteren AY (2001) Intraocular retinoblastoma: new therapeutic options. Ned Tijdschr Geneeskd 145:2165–2170

    CAS  PubMed  Google Scholar 

  41. Mehta M, Sethi S, Pushker N et al (2012) Retinoblastoma. Singapore Med J 53:128–135

    CAS  PubMed  Google Scholar 

  42. Temming P, Lohmann D, Bornfeld N, Sauerwein W, Goericke SL, Eggert A (2012) Current concepts for diagnosis and treatment of retinoblastoma in Germany: aiming for safe tumor control and vision preservation. Klin Padiatr 224:339–347

    Article  CAS  PubMed  Google Scholar 

  43. Honavar SG, Singh AD, Shields CL et al (2002) Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol 120:923–931

    Article  PubMed  Google Scholar 

  44. Sultan I, Wilson MW, Nawaiseh I et al (2010) Enucleation for retinoblastoma: the experience of a single center in Jordan. Int Ophthalmol 30:407–414

    Article  PubMed  Google Scholar 

  45. Mohney BG, Robertson DM, Schomberg PJ, Hodge DO (1998) Second nonocular tumors in survivors of heritable retinoblastoma and prior radiation therapy. Am J Ophthalmol 126:269–277

    Article  CAS  PubMed  Google Scholar 

  46. Shields CL, Honavar SG, Shields JA, Demirci H, Meadows AT, Naduvilath TJ (2002) Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol 120:460–464

    Article  PubMed  Google Scholar 

  47. Shields CL, Honavar SG, Meadows AT et al (2002) Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 133:657–664

    Article  PubMed  Google Scholar 

  48. Shields CL, Shields JA, Needle M et al (1997) Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology 104:2101–2111

    Article  CAS  PubMed  Google Scholar 

  49. Antoneli CB, Ribeiro KC, Steinhorst F, Novaes PE, Chojniak MM, Malogolowkin M (2006) Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil. J Pediatr Hematol Oncol 28:342–345

    Article  CAS  PubMed  Google Scholar 

  50. Friedman DL, Himelstein B, Shields CL et al (2000) Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 18:12–17

    CAS  PubMed  Google Scholar 

  51. Brichard B, De Bruycker JJ, De Potter P, Neven B, Vermylen C, Cornu G (2002) Combined chemotherapy and local treatment in the management of intraocular retinoblastoma. Med Pediatr Oncol 38:411–415

    Article  PubMed  Google Scholar 

  52. Gündüz K, Günalp I, Yalçindağ N et al (2004) Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Ophthalmology 111:1917–1924

    Article  PubMed  Google Scholar 

  53. Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP (2010) Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology 117:1623–1629

    Article  PubMed  Google Scholar 

  54. Shields CL, Kaliki S, Rojanaporn D, Al-Dahmash S, Bianciotto CG, Shields JA (2012) Intravenous and intra-arterial chemotherapy for retinoblastoma: what have we learned? Curr Opin Ophthalmol 23:202–209

    Article  PubMed  Google Scholar 

  55. Marr BP, Brodie SE, Dunkel IJ, Gobin YP, Abramson DH (2012) Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary results. Br J Ophthalmol 96:1300–1303

    Article  PubMed  Google Scholar 

  56. Shields CL, Kaliki S, Shah SU et al (2012) Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma. Ophthalmology 119:188–192

    Article  PubMed  Google Scholar 

  57. Shields CL, Shields JA (2010) Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol 21:203–212

    Article  PubMed  Google Scholar 

  58. Shields CL, Shields JA, Cater J, Othmane I, Singh AD, Micaily B (2001) Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology 108:2116–2121

    Article  CAS  PubMed  Google Scholar 

  59. Smit TJ, Koornneef L, Mourits MP, Groet E, Otto AJ (1990) Primary versus secondary intraorbital implants. Ophthal Plast Reconstr Surg 6:115–118

    Article  CAS  PubMed  Google Scholar 

  60. Smit TJ, Koornneef L, Zonneveld FW, Groet E, Otto AJ (1991) Primary and secondary implants in the anophthalmic orbit. Preoperative and postoperative computed tomographic appearance. Ophthalmology 98:106–110

    Article  CAS  PubMed  Google Scholar 

  61. Smit TJ, Koornneef L, Groet E, Zonneveld FW, Otto AJ (1991) Prosthesis motility with and without intraorbital implants in the anophthalmic socket. Br J Ophthalmol 75:667–670

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  62. Shoamanesh A, Pang NK, Oestreicher JH (2007) Complications of orbital implants: a review of 542 patients who have undergone orbital implantation and 275 subsequent PEG placements. Orbit 26:173–182

    Article  PubMed  Google Scholar 

  63. Smit T, Koornneef L (1990) Is an implant always necessary after enucleation? Fortschr Ophthalmol 87:533–536

    CAS  PubMed  Google Scholar 

  64. Lee V, Subak-Sharpe I, Hungerford JL, Davies NP, Logani S (2000) Exposure of primary orbital implants in postenucleation retinoblastoma patients. Ophthalmology 107:940–945

    Article  CAS  PubMed  Google Scholar 

  65. Goiato MC, Haddad MF, dos Santos DM, Pesqueira AA, Ribeiro Pdo P, Moreno A (2010) Orbital implants insertion to improve ocular prostheses motility. J Craniofac Surg 21:870–875

    Article  PubMed  Google Scholar 

  66. Trichopoulos N, Augsburger JJ (2005) Enucleation with unwrapped porous and nonporous orbital implants: a 15-year experience. Ophthal Plast Reconstr Surg 21:331–336

    Article  PubMed  Google Scholar 

  67. Van Acker E, De Potter P (2001) Porous polyethylene (Medpor) orbital implant. Prospective study of 75 primary implantations. J Fr Ophtalmol 24:1067–1073

    PubMed  Google Scholar 

  68. Li T, Shen J, Duffy MT (2001) Exposure rates of wrapped and unwrapped orbital implants following enucleation. Ophthal Plast Reconstr Surg 17:431–435

    Article  CAS  PubMed  Google Scholar 

  69. Hintschich CR, Beyer-Machule CK (1996) Dermal fat transplant as autologous orbital implant. Klin Monbl Augenheilkd 208:135–141

    Article  CAS  PubMed  Google Scholar 

  70. Smith B, Bosniak S, Nesi F, Lisman R (1983) Dermis-fat orbital implantation: 118 cases. Ophthalmic Surg 14:941–943

    CAS  PubMed  Google Scholar 

  71. Hintschich C (2003) Dermis-fat graft. Possibilities and limitations. Ophthalmologe 100:518–524

    Article  CAS  PubMed  Google Scholar 

  72. Hintschich CR, Beyer-Machule CK (1996) Dermal fatty tissue transplant as primary and secondary orbital implant. Complications and results. Ophthalmologe 93:617–622

    Article  CAS  PubMed  Google Scholar 

  73. Bosniak SL (1985) Avoiding complications following primary dermis-fat orbital implantation. Ophthal Plast Reconstr Surg 1:237–241

    Article  CAS  PubMed  Google Scholar 

  74. Taranthi A, Hintschich C (2008) Primary dermis-fat grafting in children. Orbit 27:363–369

    Article  Google Scholar 

  75. Mitchell KT, Hollsten DA, White WL, O’Hara MA (2001) The autogenous dermis-fat orbital implant in children. J AAPOS 5:367–369

    Article  CAS  PubMed  Google Scholar 

  76. Chen D, Heher K (2004) Management of the anophthalmic socket in pediatric patients. Curr Opin Ophthalmol 15:449–453

    Article  PubMed  Google Scholar 

  77. Custer PL, Trinkaus KM (2007) Porous implant exposure: incidence, management, and morbidity. Ophthal Plast Reconstr Surg 23:1–7

    Article  PubMed  Google Scholar 

  78. Tabatabaee Z, Mazloumi M, Rajabi MT et al (2011) Comparison of the exposure rate of wrapped hydroxyapatite (Bio-Eye) versus unwrapped porous polyethylene (Medpor) orbital implants in enucleated patients. Ophthal Plast Reconstr Surg 27:114–118

    Article  PubMed  Google Scholar 

  79. Custer PL, Kennedy RH, Woog JJ, Kaltreider SA, Meyer DR (2003) Orbital implants in enucleation surgery: a report by the American Academy of Ophthalmology. Ophthalmology 110:2054–2061

    Article  PubMed  Google Scholar 

  80. Jordan DR, Chan S, Mawn L et al (1999) Complications associated with pegging hydroxyapatite orbital implants. Ophthalmology 106:505–512

    Article  CAS  PubMed  Google Scholar 

  81. Lin CJ, Liao SL, Jou JR, Kao SC, Hou PK, Chen MS (2002) Complications of motility peg placement for porous hydroxyapatite orbital implants. Br J Ophthalmol 86:394–396

    Article  PubMed Central  PubMed  Google Scholar 

  82. Yazici B, Akova B, Sanli O (2007) Complications of primary placement of motility post in porous polyethylene implants during enucleation. Am J Ophthalmol 143:828–834

    Article  PubMed  Google Scholar 

  83. Karslıoğlu S, Buttanrı IB, Fazıl K, Serin D, Akbaba M (2012) Long-term outcomes of pegged and unpegged bioceramic orbital implants. Ophthal Plast Reconstr Surg 28:264–267

    Article  PubMed  Google Scholar 

  84. Wang JK, Lai PC, Liao SL (2009) Late exposure of the bioceramic orbital implant. Am J Ophthalmol 147:162–170

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

None.

Funding

None.

Conflict of interest

The authors report no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, National University Health System, Singapore, Singapore

    Priscilla Xinhui Wang, Victor Teck Chang Koh, Katherine Lun & Gangadhara Sundar

Authors
  1. Priscilla Xinhui Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Victor Teck Chang Koh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Katherine Lun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gangadhara Sundar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Priscilla Xinhui Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, P.X., Koh, V.T.C., Lun, K. et al. Survey on the management of orbital and intraocular tumors among oculofacial surgeons in the Asia-Pacific region. Int Ophthalmol 34, 723–733 (2014). https://doi.org/10.1007/s10792-013-9859-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-013-9859-7

Keywords

Search

Navigation